Our Recommendations
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Technology and Market Landscape Hepatitis C Medicines, August 2017 (2017)
- Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases (2020)
- Zika virus (ZIKV) Surveillance in the Americas: Laboratory detection and diagnosis (2016)
- Laboratory Guidance for the Diagnosis of Ebola Virus Disease (2014)
Filter
29
Featured
Recommendations
14
New Publications
7
Language
Document type
Guidelines
13
No document type
12
Manuals
2
Resource Platforms
1
Fact sheets
1
Countries / Regions
Africa
3
Latin America and the Carribbean
3
East and Southern Africa
3
Sierra Leone
2
Liberia
2
Ghana
1
Nigeria
1
Mozambique
1
Germany
1
West and Central Africa
1
Angola
1
Authors & Publishers
Publication Years
Category
Toolboxes
Diagnostics & Laboratory Guidance
14
Country specific documents
6
Laboratory Guidance
5
Genomic sequencing
4
Laboratory & Sampling
2
Zika
2
Laboratory & Diagnostics
2
Rapid Response
1
HIV testing & services
1
Clinical Aspects, Treatment & Prevention
1
Yellow Fever
1
Yellow Fever Prevention & Control
1
Public Health
1
Laboratory
1
Laboratory
1
Clinical Aspects
1
Scientific & Research Studies
1
MPOX - Monkeypox
1
Access to treatment and laboratory
1
Laboratory
1
To meet the need for laboratory diagnosis to be integrated in community care, the new 2022 Update describes point-of-care tests that can be performed both in district laboratories and peripheral healthcare facilities by non-specialist staff. Also included are recently developed self-tests.
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
8 July 2020
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
